mko2 coding sequence (Addgene inc)
Structured Review

Mko2 Coding Sequence, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 4 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mko2 coding sequence/product/Addgene inc
Average 93 stars, based on 4 article reviews
Images
1) Product Images from "HuR controls glutaminase RNA metabolism"
Article Title: HuR controls glutaminase RNA metabolism
Journal: Nature Communications
doi: 10.1038/s41467-024-49874-x
Figure Legend Snippet: MIA PaCa-2 expression levels of ELAVL1 and GLS from RNA-Seq data ( a , mean and S.E.M.) and heatmap ( b ) with bidirectional clustering of singscores from KEGG Metabolic Pathways and scaled ELAVL1 expression. The letter ‘Q’ marks pathways that involve glutamine from (Control n = 4; Knockout n = 3). The dendrograms represent full bidirectional complete clustering based on correlation values. c Chromosome 2 indicating GLS loci and exon structure for KGA and GAC isoforms. Bellow, exon differential expression after ELAVL1 knockdown in MIA PaCa-2 or HeLa cells. Asterisks denote FDR < 0.05. d , above, Western blot of doxycycline-inducible ELAVL1 -silenced breast cancer cell lines (MDA-MB-231 and BT549) using two shRNAs, displaying a marked decrease in KGA protein level, accompanied by an increase in GAC. d , below, Western blot of constitutively silenced ELAVL1 breast cancer cell lines, grouped by telaglenastat resistance, which was defined elsewhere . Arrows indicate KGA and GAC isoforms and HuR-specific bands and western blots repeated at least two times with reproducible results. e Scheme for CRISPR-mediated knock-in of the mKO2-P2A-BleoR cassette into GLS exon 19 to produce the KGA-mKO2 fusion protein. f Increase and decrease in cellular fluorescence after ELAVL1 ectopic expression (bottom) or sh ELAVL1 -mediated transient silencing (top), respectively, in HEK293T knock-in cells, number independent cells evaluated per condition >1433. Representative images on the right. The scale bar is 50 μm. g Cell cycle analysis of BT549 knock-in cells KGA levels (evaluated by mKO2 fluorescence) are enhanced in S-G2/M phases, as expected , . Representative images in bottom part, with HiLo lookup table for DNA staining, one cell with higher DNA content and higher KGA content and the opposite example below, confirming the functionality of the system. Box plots represent the interquartile range; the vertical curve is the kernel density of the distribution, and the dark horizontal line denotes the median. Each dot represents an individual cell. Statistical significance derived from bootstrapped DEXSeq ( c ) or Two-sided Welch’s t -test ( f ). * p < 0.05, ** p < 0.01, *** p < 0.0001.
Techniques Used: Expressing, RNA Sequencing, Control, Knock-Out, Quantitative Proteomics, Knockdown, Western Blot, CRISPR, Knock-In, Fluorescence, Cell Cycle Assay, Staining, Derivative Assay
Figure Legend Snippet: a Relative quantification of BT549 mRNA levels following doxycycline-inducible silencing of ELAVL1 , using qPCR for two distinct shRNA sequences. b HuR was immunoprecipitated (western blot above, arrows indicate HuR and IgG heavy chain). The control IgG were used from rabbit, in opposing to the mouse anti-HuR antibody. Quantification of mRNA derived from 3′UTR KGA regions immunoprecipitated bound in HuR from ( c ) PC-3 cells using agarose gel and ( d ) from BT549 using qRT-PCR. Quantification of mRNA derived from 3′UTR GAC regions immunoprecipitated bound in HuR from ( e ) PC-3 cells using agarose gel and ( f ) from BT549 using qRT-PCR. Agarose gel from PC-3 ( g ) and q-RT-PCR from BT549 ( h ) revealed that HuR binds to its mRNA (as already published elsewhere ) in addition to GLS intron 14. i In vitro FRAP analysis of recombinant mKO2-HuR incubated with in vitro transcribed control RNA or intron 14. The bar plot (right) denotes T 1/2 recovery times. Statistical significance derived from Two-sided Welch’s t-test ( a , d , f , h , and i ), error bars are SEM; qRT-PCR assays were evaluated in triplicate; otherwise, each point represents a replicate. * p < 0.05, ** p < 0.01, *** p < 0.0001.
Techniques Used: Quantitative Proteomics, shRNA, Immunoprecipitation, Western Blot, Control, Derivative Assay, Agarose Gel Electrophoresis, Quantitative RT-PCR, Reverse Transcription Polymerase Chain Reaction, In Vitro, Recombinant, Incubation
